Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cy-Tb for Detecting Mycobacterium Tuberculosis Infection in Indonesian Population
Sponsor: PT Bio Farma
Summary
TB is caused by the bacillus Mycobacterium tuberculosis, which is spread when people who are sick with TB expel bacteria into the air (e.g. by droplet or coughing). About a quarter of the global population is estimated to have been infected with TB. Following infection, the risk of developing TB disease is highest in the first 2 years (approximately 5%), after which it is much lower. Some people will clear the infection. Of the total number of people who develop TB disease each year, about 90% are adults, with more cases among men than women. The disease typically affects the lungs (pulmonary TB) but can affect other sites as well. Passive detection of TB through healthcare facility attendance alone is inadequate to identify all individuals with TB disease. Ongoing case-detection gaps, particularly in vulnerable groups, along with diagnostic delays and continued community transmission, emphasize the need for more active TB case-finding strategies. Systematic screening for TB disease among populations at high risk is a core element of the first pillar of the WHO End TB Strategy, aiming to promote the early identification and diagnosis of all individuals with TB. This study aims to compare the Cy-Tb test with the IGRA (blood test) to detect TB infection in individuals who are close contacts and household contacts of patients with TB. The study also aims to evaluate the safety of the Cy-Tb test, the costs and benefits of its use, and participants' opinions regarding the Cy-Tb test compared with the IGRA.
Key Details
Gender
All
Age Range
1 Year - 65 Years
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2026-10-12
Completion Date
2027-01-31
Last Updated
2026-11-10
Healthy Volunteers
Yes
Conditions
Interventions
Cy-Tb test
Participants will undergo a small Cy-Tb injection into the skin of the arm. Participants and their parents/guardians will receive a card to record any local symptoms, such as redness or itching, following the injection.
IGRA test
A small amount of blood will be collected from the participant's arm for IGRA testing.
Locations (1)
Persahabatan Hospital
Jakarta Pusat, Jakarta Special Capital Region, Indonesia